Enterprise Value
3.251M
Cash
38.79M
Avg Qtr Burn
-7.941M
Short % of Float
0.00%
Insider Ownership
0.00%
Institutional Own.
7.65%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Eryaspase (GRASPA) (asparaginase) Details Leukemia, Acute lymphoblastic leukemia, Cancer | Failed Discontinued | |
Eryaspase (GRASPA) (asparaginase) Details Pancreatic cancer, Cancer | Failed Discontinued | |
Eryaspase (GRASPA) (asparaginase) Details Pancreatic cancer, Solid tumor/s, Cancer | Failed Discontinued | |
Eryaspase (GRASPA) (asparaginase) Details Breast cancer, Triple-negative breast cancer , Cancer | Failed Discontinued |